Literature DB >> 18268082

Potential basis for amphotericin B resistance in Aspergillus terreus.

Gerhard Blum1, Susanne Perkhofer, Hubertus Haas, Markus Schrettl, Reinhard Würzner, Manfred P Dierich, Cornelia Lass-Flörl.   

Abstract

This study investigated the basis for intrinsic amphotericin B (AMB) resistance in Aspergillus terreus. The ergosterol content, cell wall composition, and lipid peroxidation level had no influence on AMB resistance. The level of catalase production in A. terreus was significantly higher than that in A. fumigatus (P < 0.05). This higher-level production may contribute to AMB resistance in A. terreus since oxidative damage has been implicated in AMB action.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18268082      PMCID： PMC2292529          DOI： 10.1128/AAC.01280-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

1.  Lipid composition and polyene antibiotic resistance of Candida albicans mutants.

Authors:  A M Pierce; H D Pierce; A M Unrau; A C Oehlschlager
Journal:  Can J Biochem       Date:  1978-02

2.  In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole.

Authors:  E Dannaoui; F Persat; M F Monier; E Borel; M A Piens; S Picot
Journal:  J Antimicrob Chemother       Date:  1999-10       Impact factor: 5.790

Review 3.  Mechanisms and clinical impact of antifungal drug resistance.

Authors:  H Vanden Bossche; D W Warnock; B Dupont; D Kerridge; S Sen Gupta; L Improvisi; P Marichal; F C Odds; F Provost; O Ronin
Journal:  J Med Vet Mycol       Date:  1994

4.  Catalase in vitro.

Authors:  H Aebi
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

5.  In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.

Authors:  D A Sutton; S E Sanche; S G Revankar; A W Fothergill; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

6.  Production of catalases by Aspergillus niger isolates as a response to pollutant stress by heavy metals.

Authors:  Maria Bucková; Jana Godocíková; Alexandra Simonovicová; Bystrík Polek
Journal:  Curr Microbiol       Date:  2005-03-15       Impact factor: 2.188

7.  Two divergent catalase genes are differentially regulated during Aspergillus nidulans development and oxidative stress.

Authors:  L Kawasaki; D Wysong; R Diamond; J Aguirre
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

8.  Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis.

Authors:  E Dannaoui; E Borel; F Persat; M A Piens; S Picot
Journal:  J Med Microbiol       Date:  2000-07       Impact factor: 2.472

9.  Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans.

Authors:  B A Arthington-Skaggs; H Jradi; T Desai; C J Morrison
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

10.  Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.

Authors:  Thomas J Walsh; Vidmantas Petraitis; Ruta Petraitiene; Aida Field-Ridley; Deanna Sutton; Mahmoud Ghannoum; Tin Sein; Robert Schaufele; Joanne Peter; John Bacher; Heather Casler; Derek Armstrong; Anna Espinel-Ingroff; Michael G Rinaldi; Caron A Lyman
Journal:  J Infect Dis       Date:  2003-07-09       Impact factor: 5.226
View more
  41 in total

1.  Extracellular proteome of Aspergillus terreus grown on different carbon sources.

Authors:  Mee-Jung Han; Nag-Jong Kim; Sang Yup Lee; Ho Nam Chang
Journal:  Curr Genet       Date:  2010-06-08       Impact factor: 3.886

2.  Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani.

Authors:  Bidyut Purkait; Ashish Kumar; Nilay Nandi; Abul Hasan Sardar; Sushmita Das; Sudeep Kumar; Krishna Pandey; Vidyananda Ravidas; Manish Kumar; Tripti De; Dharmendra Singh; Pradeep Das
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

3.  Cell Wall Changes in Amphotericin B-Resistant Strains from Candida tropicalis and Relationship with the Immune Responses Elicited by the Host.

Authors:  Ana C Mesa-Arango; Cristina Rueda; Elvira Román; Jessica Quintin; María C Terrón; Daniel Luque; Mihai G Netea; Jesus Pla; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

4.  The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.

Authors:  Ana Cecilia Mesa-Arango; Nuria Trevijano-Contador; Elvira Román; Ruth Sánchez-Fresneda; Celia Casas; Enrique Herrero; Juan Carlos Argüelles; Jesús Pla; Manuel Cuenca-Estrella; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

Review 5.  The Emerging Threat of Antifungal Resistance in Transplant Infectious Diseases.

Authors:  Ilan S Schwartz; Thomas F Patterson
Journal:  Curr Infect Dis Rep       Date:  2018-02-05       Impact factor: 3.725

6.  Monoclonal antibodies to hyphal exoantigens derived from the opportunistic pathogen Aspergillus terreus.

Authors:  Ajay P Nayak; Brett J Green; Erika Janotka; Justin M Hettick; Sherri Friend; Steve J Vesper; Detlef Schmechel; Donald H Beezhold
Journal:  Clin Vaccine Immunol       Date:  2011-07-06

7.  The First Case of Total Dystrophic Onychomycosis Caused by Aspergillus clavatus Resistant to Antifungal Drugs.

Authors:  Mehraban Falahati; Aynaz Ghojoghi; Mahdi Abastabar; Zeinab Ghasemi; Shirin Farahyar; Maryam Roudbary; Mohammad Taghi Hedayati; Mojtaba Taghizadeh Armaki; Akbar Hoseinnejad
Journal:  Mycopathologia       Date:  2015-10-16       Impact factor: 2.574

8.  In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto.

Authors:  Mariana S Fernández; Florencia D Rojas; María E Cattana; María de Los Ángeles Sosa; Cristina A Iovannitti; Cornelia Lass-Flörl; Gustavo E Giusiano
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

9.  Single-dose pharmacodynamics of amphotericin B against Aspergillus species in an in vitro pharmacokinetic/pharmacodynamic model.

Authors:  Rafal Al-Saigh; Maria Siopi; Nikolaos Siafakas; Aristea Velegraki; Loukia Zerva; Joseph Meletiadis
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

Review 10.  Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Authors:  Marit D Moen; Katherine A Lyseng-Williamson; Lesley J Scott
Journal:  Drugs       Date:  2009       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.